Acute upper gastrointestinal bleeding in octogenarians: Clinical outcome and factors related to mortality

Table 2 Causes of acute upper gastrointestinal bleeding (AUGIB)-endoscopic findings according to age n (%)

	Group A (65-80 yr)	Group B (> 80 yr)	P (odds ratio)
No endoscopy	2/269 (0.7)	15/147 (10.2)	< 0.0001 (0.015-0.29)
No findings	10/267 (3.7)	6/132 (4.5)	NS
Peptic ulcer	141/267 (52.8)	68/132 (51.5)	NS
Gastric ulcer	68/141 (48.2)	37/68 (54.4)	NS
Duodenal ulcer	73/141 (51.7)	33/68 (48.5)	NS
Varices	20/267 (7.4)	1/132 (0.7)	0.0094 (1.4-79.92)
Erosive gastroduodenitis	61/267 (22.8)	25/132 (18.9)	NS
Angiodysplasia	6/267 (2.2)	12/132 (9.0)	0.005 (0.08-0.62)
Mallory-Weiss	3/267 (1.1)	0/132 (0.0)	NS
Polyps	6/267 (2.2)	1/132 (0.7)	NS
Esophagitis	5/267 (1.8)	9/132 (6.8)	0.025 (0.08-0.79)
Neoplasia	15/267 (5.6)	10/132 (7.5)	NS
Stigmata of bleeding in peptic ulcer bleeding patients
High risk stigmata	36/141 (25.5)	12/68 (17.6)	NS
Low risk stigmata	105/141 (74.4)	56/68 (82.3)	NS
F1a	7/141 (4.9)	3/68 (4.4)	NS
F1b	13/141 (9.2)	5/68 (7.3)	NS
F2a	16/141 (11.3)	4/68 (5.8)	NS
F2b	32/141 (22.6)	13/68 (19.1)	NS
F2c	8/141 (5.6)	7/68 (10.2)	NS
F3	65/141 (46.0)	37/68 (54.4)	NS
Ulcer diameter < 1 cm	117/141 (82.9)	57/68 (83.8)	NS
Ulcer diameter > 1 cm	24/141 (17.0)	11/68 (16.1)	NS
Endoscopic therapy	78/267 (29.2)	28/132 (21.2)	NS

NSAIDs: Non-steroidal anti-inflammatory drugs; F: Forrest; NS: No significance.